{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T04:48:30Z","timestamp":1773204510585,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,12,26]],"date-time":"2012-12-26T00:00:00Z","timestamp":1356480000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s10157-012-0759-3","type":"journal-article","created":{"date-parts":[[2012,12,25]],"date-time":"2012-12-25T06:32:04Z","timestamp":1356417124000},"page":"515-524","source":"Crossref","is-referenced-by-count":12,"title":["Renoprotective mechanisms of telmisartan on renal injury and inflammation in SHRSP.Z-Leprfa\/IzmDmcr rats"],"prefix":"10.1007","volume":"17","author":[{"given":"Fumihiro","family":"Sugiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiko","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Onoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Ishimitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,26]]},"reference":[{"key":"759_CR1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1440-1681.2004.03962.x","volume":"31","author":"J Hiraoka-Yamamoto","year":"2004","unstructured":"Hiraoka-Yamamoto J, Nara Y, Yasui N, Onobayashi Y, Tsuchikura S, Ikeda K. Establishment of a new animal model of metabolic syndrome: SHRSP fatty (fa\/fa) rats. Clin Exp Pharmacol Physiol. 2004;31:107\u20139.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"759_CR2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1440-1681.2010.05432.x","volume":"37","author":"S Kagota","year":"2010","unstructured":"Kagota S, Fukushima K, Umetani K, Tada Y, Nejime N, Nakamura K, et al. Coronary vascular dysfunction promoted by oxidative-nitrative stress in SHRSP.Z-Lepr(fa) \/IzmDmcr rats with metabolic syndrome. Clin Exp Pharmacol Physiol. 2010;37:1035\u201343.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"759_CR3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1291\/hypres.31.1021","volume":"31","author":"T Ueno","year":"2008","unstructured":"Ueno T, Takagi H, Fukuda N, Takahashi A, Yao EH, Mitsumata M, et al. Cardiovascular remodeling and metabolic abnormalities in SHRSP.Z-Lepr(fa)\/IzmDmcr rats as a new model of metabolic syndrome. Hypertens Res. 2008;31:1021\u201331.","journal-title":"Hypertens Res"},{"key":"759_CR4","doi-asserted-by":"crossref","first-page":"86A","DOI":"10.1016\/0735-1097(93)90468-G","volume":"22","author":"RR Brandt","year":"1993","unstructured":"Brandt RR, Wright RS, Redfield MM, Burnett JC Jr. Atrial natriuretic peptide in heart failure. J Am Coll Cardiol. 1993;22:86A\u201392A.","journal-title":"J Am Coll Cardiol"},{"key":"759_CR5","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1097\/01.ASN.0000033611.79556.AE","volume":"13","author":"EP B\u00f6ttinger","year":"2002","unstructured":"B\u00f6ttinger EP, Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol. 2002;13:2600\u201310.","journal-title":"J Am Soc Nephrol"},{"key":"759_CR6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5000054","volume":"69","author":"Y Liu","year":"2006","unstructured":"Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 2006;69:213\u20137.","journal-title":"Kidney Int"},{"key":"759_CR7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi Y, Massagu\u00e9 J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113:685\u2013700.","journal-title":"Cell"},{"key":"759_CR8","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1091\/mbc.E04-08-0658","volume":"16","author":"U Valcourt","year":"2005","unstructured":"Valcourt U, Kowanetz M, Niimi H, Heldin CH, Moustakas A. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell. 2005;16:1987\u20132002.","journal-title":"Mol Biol Cell"},{"key":"759_CR9","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1096\/fj.03-0037fje","volume":"17","author":"T Hayashida","year":"2003","unstructured":"Hayashida T, Decaestecker M, Schnaper HW. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. FASEB J. 2003;17:1576\u20138.","journal-title":"FASEB J"},{"key":"759_CR10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1681\/ASN.2004050425","volume":"16","author":"DY Rhyu","year":"2005","unstructured":"Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh ST, et al. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol. 2005;16:667\u201375.","journal-title":"J Am Soc Nephrol"},{"key":"759_CR11","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/hr.2010.112","volume":"33","author":"Y Takeda","year":"2010","unstructured":"Takeda Y, Nishikimi T, Akimoto K, Matsuoka H, Ishimitsu T. Beneficial effects of a combination of Rho-kinase inhibitor and ACE inhibitor on tubulointerstitial fibrosis induced by unilateral ureteral obstruction. Hypertens Res. 2010;33:965\u201373.","journal-title":"Hypertens Res"},{"key":"759_CR12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/374131a0","volume":"374","author":"DO Morgan","year":"1995","unstructured":"Morgan DO. Principles of CDK regulation. Nature. 1995;374:131\u20134.","journal-title":"Nature"},{"key":"759_CR13","doi-asserted-by":"crossref","first-page":"7060","DOI":"10.1002\/j.1460-2075.1996.tb01097.x","volume":"15","author":"M Kitagawa","year":"1996","unstructured":"Kitagawa M, Higashi H, Jung HK, Suzuki-Takahashi I, Ikeda M, Tamai K, et al. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A\/E-Cdk2. EMBO J. 1996;15:7060\u20139.","journal-title":"EMBO J"},{"key":"759_CR14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/ajh.2008.27","volume":"21","author":"N Kobayashi","year":"2008","unstructured":"Kobayashi N, Ohno T, Yoshida K, Fukushima H, Mamada Y, Nomura M, et al. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats. Am J Hypertens. 2008;21:576\u201381.","journal-title":"Am J Hypertens"},{"key":"759_CR15","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/HJH.0b013e32814db89f","volume":"25","author":"K Yoshida","year":"2007","unstructured":"Yoshida K, Kobayashi N, Ohno T, Fukushima H, Matsuoka H. Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats. J Hypertens. 2007;25:1633\u201342.","journal-title":"J Hypertens"},{"key":"759_CR16","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/01.HYP.0000157408.43807.5a","volume":"45","author":"N Kobayashi","year":"2005","unstructured":"Kobayashi N, Hara K, Tojo A, Onozato ML, Honda T, Yoshida K, et al. Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCepsilon-MAPK-p90RSK, and Rho-kinase pathway. Hypertension. 2005;45:538\u201344.","journal-title":"Hypertension"},{"key":"759_CR17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.regpep.2009.02.006","volume":"154","author":"T Nishikimi","year":"2009","unstructured":"Nishikimi T, Inaba-Iemura C, Ishimura K, Tadokoro K, Koshikawa S, Ishikawa K, et al. Natriuretic peptide\/natriuretic peptide receptor-A (NPR-A) system has inhibitory effects in renal fibrosis in mice. Regul Pept. 2009;154:44\u201353.","journal-title":"Regul Pept"},{"key":"759_CR18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5551\/jat.11114","volume":"19","author":"H Takeshima","year":"2012","unstructured":"Takeshima H, Kobayashi N, Koguchi W, Ishikawa M, Sugiyama F, Ishimitsu T. Cardioprotective effect of a combination of Rho-kinase inhibitor and p38 MAPK inhibitor on cardiovascular remodeling and oxidative stress in Dahl rats. J Atheroscler Thromb. 2012;19:326\u201336.","journal-title":"J Atheroscler Thromb"},{"key":"759_CR19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/01.HYP.0000203148.42892.7a","volume":"47","author":"N Kobayashi","year":"2006","unstructured":"Kobayashi N, Yoshida K, Nakano S, Ohno T, Honda T, Tsubokou Y, et al. Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts. Hypertension. 2006;47:671\u20139.","journal-title":"Hypertension"},{"key":"759_CR20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ajh.2008.333","volume":"22","author":"N Kobayashi","year":"2009","unstructured":"Kobayashi N, Takeshima H, Fukushima H, Koguchi W, Mamada Y, Hirata H, et al. Cardioprotective effects of pitavastatin on cardiac performance and remodeling in failing rat hearts. Am J Hypertens. 2009;22:176\u201382.","journal-title":"Am J Hypertens"},{"key":"759_CR21","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/diabetes.54.6.1626","volume":"54","author":"G Wolf","year":"2005","unstructured":"Wolf G, Chen S, Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes. 2005;54:1626\u201334.","journal-title":"Diabetes"},{"key":"759_CR22","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1124\/jpet.109.158113","volume":"332","author":"A Nishiyama","year":"2010","unstructured":"Nishiyama A, Kobori H, Konishi Y, Morikawa T, Maeda I, Okumura M, et al. Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats. J Pharmacol Exp Ther. 2010;332:1072\u201380.","journal-title":"J Pharmacol Exp Ther"},{"key":"759_CR23","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1097\/HJH.0b013e3283060efa","volume":"26","author":"A Nishiyama","year":"2008","unstructured":"Nishiyama A, Nakagawa T, Kobori H, Nagai Y, Okada N, Konishi Y, et al. Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria. J Hypertens. 2008;26:1849\u201359.","journal-title":"J Hypertens"},{"key":"759_CR24","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1093\/ndt\/gfr096","volume":"26","author":"L Villa","year":"2011","unstructured":"Villa L, Boor P, Konieczny A, Kunter U, van Roeyen CR, Denecke B, et al. Effects and mechanisms of angiotensin II receptor blockade with telmisartan in a normotensive model of mesangioproliferative nephritis. Nephrol Dial Transplant. 2011;26:3131\u201343.","journal-title":"Nephrol Dial Transplant"},{"key":"759_CR25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cellsig.2011.09.022","volume":"24","author":"Z Ren","year":"2012","unstructured":"Ren Z, Liang W, Chen C, Yang H, Singhal PC, Ding G. Angiotensin II induces nephrin dephosphorylation and podocyte injury: role of caveolin-1. Cell Signal. 2012;24:443\u201350.","journal-title":"Cell Signal"},{"key":"759_CR26","doi-asserted-by":"crossref","first-page":"F734","DOI":"10.1152\/ajprenal.00415.2009","volume":"298","author":"A Yadav","year":"2010","unstructured":"Yadav A, Vallabu S, Kumar D, Ding G, Charney DN, Chander PN, et al. HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation. Am J Physiol Renal Physiol. 2010;298:F734\u201344.","journal-title":"Am J Physiol Renal Physiol"},{"key":"759_CR27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cbi.2010.03.008","volume":"185","author":"SR Mulay","year":"2010","unstructured":"Mulay SR, Gaikwad AB, Tikoo K. Combination of aspirin with telmisartan suppresses the augmented TGFbeta\/smad signaling during the development of streptozotocin-induced type I diabetic nephropathy. Chem Biol Interact. 2010;185:137\u201342.","journal-title":"Chem Biol Interact"},{"key":"759_CR28","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1101\/gad.181700","volume":"14","author":"K Lehmann","year":"2000","unstructured":"Lehmann K, Janda E, Pierreux CE, Ryt\u00f6maa M, Schulze A, McMahon M, et al. Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev. 2000;14:2610\u201322.","journal-title":"Genes Dev"},{"key":"759_CR29","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1161\/01.CIR.0000161831.07637.63","volume":"111","author":"ZG Xu","year":"2005","unstructured":"Xu ZG, Lanting L, Vaziri ND, Li Z, Sepassi L, Rodriguez-Iturbe B, et al. Upregulation of angiotensin II type 1 receptor, inflammatory mediators, and enzymes of arachidonate metabolism in obese Zucker rat kidney: reversal by angiotensin II type 1 receptor blockade. Circulation. 2005;111:1962\u20139.","journal-title":"Circulation"},{"key":"759_CR30","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/HJH.0b013e3282f56ba5","volume":"26","author":"SC Benson","year":"2008","unstructured":"Benson SC, Iguchi R, Ho CI, Yamamoto K, Kurtz TW. Inhibition of cardiovascular cell proliferation by angiotensin receptor blockers: are all molecules the same? J Hypertens. 2008;26:973\u201380.","journal-title":"J Hypertens"},{"key":"759_CR31","first-page":"1893","volume":"27","author":"N Du","year":"2012","unstructured":"Du N, Feng J, Hu LJ, Sun X, Sun HB, Zhao Y, et al. Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling. Oncol Rep. 2012;27:1893\u2013903.","journal-title":"Oncol Rep"},{"key":"759_CR32","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/jcp.20967","volume":"211","author":"HJ Han","year":"2007","unstructured":"Han HJ, Han JY, Heo JS, Lee SH, Lee MY, Kim YH. ANG II-stimulated DNA synthesis is mediated by ANG II receptor-dependent Ca(2+)\/PKC as well as EGF receptor-dependent PI3\u00a0K\/Akt\/mTOR\/p70S6K1 signal pathways in mouse embryonic stem cells. J Cell Physiol. 2007;211:618\u201329.","journal-title":"J Cell Physiol"},{"key":"759_CR33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1291\/hypres.28.593","volume":"28","author":"S Takai","year":"2005","unstructured":"Takai S, Kirimura K, Jin D, Muramatsu M, Yoshikawa K, Mino Y, et al. Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling. Hypertens Res. 2005;28:593\u2013600.","journal-title":"Hypertens Res"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-012-0759-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-012-0759-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-012-0759-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T15:27:34Z","timestamp":1562513254000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-012-0759-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,26]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["759"],"URL":"https:\/\/doi.org\/10.1007\/s10157-012-0759-3","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,26]]}}}